Kimia Biosciences Limited Share Latest Deal, Order Book, Capex, Fund Raise (QIP, Preferential), Split, Bonus, Buyback News Today
In Kimia Biosciences Limited Share Latest News Today blog, we will follow Kimia Biosciences Limited from the eyes of a long term investor. Here we will cover all the recent updates of Kimia Biosciences Limited Share regarding its Latest Deal, Order Book, Capex, Fund Raise (QIP, Preferential etc.), Split, Bonus, Buyback News.
Every current or potential long term investor of Kimia Biosciences Limited should follow this page and be updated regarding Kimia Biosciences Limited Share Latest Deal, Order Book, Capex, Fund Raise (QIP, Preferential etc.), Split, Bonus, Buyback News.
To watch our YouTube Videos regarding daily updates of your Portfolio Stocks (Explained in Hindi over English language PPT)– Click Here
Kimia Biosciences Limited share latest news today regarding new deal or order updates-
16 September 2024
- Kimia Biosciences Limited (share latest news today) has received an International Order from a reputed client based in Europe. The contract is related to contract development and manufacturing organization (CDMO), worth of USD 200,000/-.
Disclaimer-
In Kimia Biosciences Limited Share Latest News Today blog All information regarding Kimia Biosciences Limited Share Latest Deal, Order Book, Capex, Fund Raise (QIP, Preferential etc.), Split, Bonus, Buyback News are directly derived from the updates provided by the Kimia Biosciences Limited to Stock Exchanges ie NSE and BSE. we are sharing these information for the ease of fundamental research of Kimia Biosciences Limited Share. We (www.finofreedom.com) are not recommending to buy or sell of Kimia Biosciences Limited Share.
If you want to invest on Kimia Biosciences Limited Share or any other stock based on shared information then please consult your financial advisor before taking any decision. We (www.finofreedom.com) will not be responsible for any of your investment outcome either profit or loss in case you take any decision based on these information.
